Degenerative and regenerative signaling pathways in restoration injured RGCs and melatonin future prospect for their survival

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 41

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CSUMSMED08_231

تاریخ نمایه سازی: 22 آذر 1402

چکیده مقاله:

Background & Objectives: Optic neuropathies are related to the conditions in which optic nerve fibers are degenerated by any reasons including inflammation, trauma, ischemia, mitochondrial dysfunction, etc. The neurons of the retina including retinal ganglion cells (RGCs) inherently face a limited ability regenerate axons after either disease or trauma, thereby resulting in irreversible vision loss. In this review, we discussed the detailed cellular and molecular mechanisms affecting axonal regeneration in the visual system after optic neuropathy and then we demonstrated that how melatonin might physiologically and pharmacologically play an important role in the management of optic neuropathy.Materials & Methods: In November ۲۰۱۸, we searched literature in PubMed, google scholar, web of sciences, Scopus, and other databases for published studies. The key terms included "retinal ganglion cell survival/death", "inflammation", "oxidative stress", "apoptosis", "melatonin", "excitotoxic damage", and "hypoxia".Results: Melatonin as a wide-spectrum antioxidant and powerful free radical scavenger is able to defend RGCs against a variety of harmful circumstances including inflammation (attenuating the production of proinflammatory cytokines such as IL-۱β and TNF-α), oxidative/nitrosative stress (decrease in the electron leakage from the mitochondrial electron transport chain), glutamate-mediated neurotoxicity, apoptosis, and HIF-۱α expression in the retina. Furthermore, we found that melatonin may have a protective effect on RGCs via its effects on neurotrophic factors such as BDNF. Therefore, melatonin may be a new therapeutic medication that will assist scientists to mitigate RGC death.Conclusions: According to the key information provided in this examination, melatonin may act as a promising medication to diminish RGC death in numerous retinal pathologic circumstances.

نویسندگان

Kobra Bahrampour Juybari

Department of Pharmacology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Azam Hosseinzadeh

Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran

Habib Ghaznavi

Department of Pharmacology, Zahedan University of Medical Sciences, Zahedan, Iran

Saeed Mehrzadi

Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran

Zahra Halimi

Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran

Masood Naseripour

Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran